{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "558111", "DateCompleted": {"Year": "1977", "Month": "06", "Day": "11"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"Language": ["rus"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0014-8318", "JournalIssue": {"Volume": "40", "Issue": "1", "PubDate": {"Year": "1977", "Season": "Jan-Feb"}}, "Title": "Farmakologiia i toksikologiia", "ISOAbbreviation": "Farmakol Toksikol"}, "ArticleTitle": "[Effect of lithium chloride on several indices of cardiac function].", "Pagination": {"StartPage": "33", "EndPage": "36", "MedlinePgn": "33-6"}, "Abstract": {"AbstractText": ["Used in a dose of 100 mg/kg lithium chloride modifies the ECG patterns in rats, rabbits and cats. It increases the voltage of P and R waves, the S-T interval and slows down the rhythm of cardiac contractions. In doses of 50-300 mg/kg the compound raises the coronary circulation rate in narcotized cats. The compound exerts an antiarrhythmic action in chlorocalcium arrhythmia in rats, in strophanthin-induced one in cats and frogs and the intensity of this action is not inferior to that produced by potassium chloride, quinidine, novacainamide, izoptin and even exceeds it."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [], "LastName": "Stoliarchuk", "ForeName": "A A", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Umanets", "ForeName": "V S", "Initials": "VS"}], "PublicationTypeList": ["Comparative Study", "English Abstract", "Journal Article"], "VernacularTitle": "Vliianie litiia khlorida na nekotorye pokazateli funktsii serdtsa."}, "MedlineJournalInfo": {"Country": "Russia (Federation)", "MedlineTA": "Farmakol Toksikol", "NlmUniqueID": "16920420R", "ISSNLinking": "0014-8318"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Arrhythmia Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Strophanthins"}, {"RegistryNumber": "4Z8Y51M438", "NameOfSubstance": "Procaine"}, {"RegistryNumber": "660YQ98I10", "NameOfSubstance": "Potassium Chloride"}, {"RegistryNumber": "9FN79X2M3F", "NameOfSubstance": "Lithium"}, {"RegistryNumber": "CJ0O37KU29", "NameOfSubstance": "Verapamil"}, {"RegistryNumber": "ITX08688JL", "NameOfSubstance": "Quinidine"}, {"RegistryNumber": "M4I0D6VV5M", "NameOfSubstance": "Calcium Chloride"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Anti-Arrhythmia Agents"}, {"QualifierName": [], "DescriptorName": "Anura"}, {"QualifierName": ["chemically induced", "prevention & control"], "DescriptorName": "Arrhythmias, Cardiac"}, {"QualifierName": [], "DescriptorName": "Calcium Chloride"}, {"QualifierName": [], "DescriptorName": "Cats"}, {"QualifierName": ["drug effects"], "DescriptorName": "Coronary Circulation"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["drug effects"], "DescriptorName": "Heart"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Lithium"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Potassium Chloride"}, {"QualifierName": [], "DescriptorName": "Procaine"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Quinidine"}, {"QualifierName": [], "DescriptorName": "Rabbits"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Strophanthins"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Verapamil"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1977", "Month": "1", "Day": "1"}, {"Year": "1977", "Month": "1", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1977", "Month": "1", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["558111"]}}]}